{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:33:19Z","timestamp":1760452399471},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.toxlet.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T05:48:19Z","timestamp":1263880099000},"page":"183-188","source":"Crossref","is-referenced-by-count":20,"title":["Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: Investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines"],"prefix":"10.1016","volume":"193","author":[{"given":"Radim","family":"Vrzal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Kubesova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Pavek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2010.01.004_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2009.08.009","article-title":"Examination of Zolpidem effects on AhR- and PXR-dependent expression of drug-metabolizing cytochromes P450 in primary cultures of human hepatocytes","volume":"191","author":"Bachleda","year":"2009","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.toxlet.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/dmd.106.014456","article-title":"Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane x receptor pathways","volume":"35","author":"Cerveny","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.toxlet.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/YCO.0b013e32831a473d","article-title":"Current use of benzodiazepines in anxiety disorders","volume":"22","author":"Cloos","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"issue":"17\u201318","key":"10.1016\/j.toxlet.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","article-title":"The complexity of the GABAA receptor shapes unique pharmacological profiles","volume":"14","author":"D\u2019Hulst","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.toxlet.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bcp.2007.09.013","article-title":"JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes","volume":"75","author":"Dvorak","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.toxlet.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cellsig.2005.07.007","article-title":"Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide","volume":"18","author":"Gerbal-Chaloin","year":"2006","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.toxlet.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/mol.56.6.1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.toxlet.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/mol.107.039354","article-title":"Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4{alpha} to the proximal promoter","volume":"73","author":"Onica","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.toxlet.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1081\/DMR-120026394","article-title":"Pathophysiological factors affecting CAR gene expression","volume":"35","author":"Pascussi","year":"2003","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.toxlet.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia","volume":"115","author":"Pascussi","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.toxlet.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105349","article-title":"The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences","volume":"48","author":"Pascussi","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.toxlet.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.placenta.2007.05.001","article-title":"Examination of glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines","volume":"28","author":"Pavek","year":"2007","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.toxlet.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920008783571774","article-title":"Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues","volume":"9","author":"Pavek","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.toxlet.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0076-6879(02)57689-8","article-title":"Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression","volume":"357","author":"Pichard-Garcia","year":"2002","journal-title":"Methods Enzymol."},{"issue":"5","key":"10.1016\/j.toxlet.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1124\/mol.109.055699","article-title":"Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family","volume":"76","author":"Riffel","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxlet.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","volume":"6","author":"Rudolph","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.toxlet.2010.01.004_bib17","first-page":"447","article-title":"Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics","volume":"58","author":"Schulz","year":"2003","journal-title":"Pharmazie"},{"issue":"4","key":"10.1016\/j.toxlet.2010.01.004_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138920006776873535","article-title":"Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions","volume":"7","author":"Sinz","year":"2006","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.toxlet.2010.01.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm00187a001","article-title":"The benzodiazepine story","volume":"22","author":"Sternbach","year":"1979","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.toxlet.2010.01.004_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1124\/dmd.107.018341","article-title":"Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression","volume":"36","author":"Svecova","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"36","key":"10.1016\/j.toxlet.2010.01.004_bib21","doi-asserted-by":"crossref","first-page":"32453","DOI":"10.1074\/jbc.M111245200","article-title":"Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics","volume":"277","author":"Takeshita","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.toxlet.2010.01.004_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cbi.2008.10.035","article-title":"Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes","volume":"179","author":"Vrzal","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.toxlet.2010.01.004_bib23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bcp.2005.06.016","article-title":"Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: biphasic effect on CYP1A1","volume":"70","author":"Vrzal","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.toxlet.2010.01.004_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2009.03.003","article-title":"PXR and CAR in energy metabolism","volume":"20","author":"Wada","year":"2009","journal-title":"Trends Endocrinol. Metab."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427410000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427410000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T02:42:10Z","timestamp":1558752130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427410000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0378427410000184"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2010.01.004","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}